# Immunogenicity of Fluzone High Dose in Immunocompromised Children and Young Adults

> **NCT01685372** · PHASE2 · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 16 (actual)

## Conditions studied

- Solid Organ Transplant Recipient (Liver, Kidney, Heart)
- Rheumatologic Disorder
- Human Immunodeficiency Virus (HIV)
- Bone Marrow Transplant (BMT)
- Dialysis

## Interventions

- **BIOLOGICAL:** Fluzone High Dose
- **BIOLOGICAL:** Fluzone

## Key facts

- **NCT ID:** NCT01685372
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2015-09
- **Final completion:** 2017-09
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2018-01-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01685372

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01685372, "Immunogenicity of Fluzone High Dose in Immunocompromised Children and Young Adults". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT01685372. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*